These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6251193)

  • 1. Renal prostaglandin E2 in nephrogenic diabetes insipidus: effects of inhibition of prostaglandin synthesis by indomethacin.
    Usberti M; Dechaux M; Guillot M; Seligmann R; Pavlovitch H; Loirat C; Sachs C; Broyer M
    J Pediatr; 1980 Sep; 97(3):476-8. PubMed ID: 6251193
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal prostaglandins and water balance: studies in normal volunteer subjects and in patients with central diabetes insipidus.
    Düsing R; Herrmann R; Glänzer K; Vetter H; Overlack A; Kramer HJ
    Clin Sci (Lond); 1981 Jul; 61(1):61-7. PubMed ID: 6265142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of renal prostaglandins during antidiuresis and water diuresis in man.
    Walker RM; Brown RS; Stoff JS
    Kidney Int; 1982 Feb; 21(2):365-70. PubMed ID: 6951096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The renal prostaglandin system in central diabetes insipidus: effects of desamino-arginine vasopressin.
    Düsing R; Herrmann R; Kramer HJ
    Adv Prostaglandin Thromboxane Res; 1980; 7():1111-3. PubMed ID: 6245565
    [No Abstract]   [Full Text] [Related]  

  • 5. 1-Deamino-8-D-arginine vasopressin and urine cyclic adenosine monophosphate excretion in diabetes insipidus.
    Blackett PR; Seely JR; Altmiller DH; Males JL
    Clin Pharmacol Ther; 1981 Jun; 29(6):793-7. PubMed ID: 6262005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of familial central diabetes insipidus: the response of urinary prostaglandins to 1-deamino-8-D-arginine vasopressin.
    Sasaki Y; Higashihara E; Takeuchi T; Nutahara K; Homma Y; Aso Y
    J Urol; 1994 Jul; 152(1):161-3. PubMed ID: 8201652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of vasopressin and renal prostaglandins in the homozygous diabetes insipidus rat.
    Dunn MJ; Kinter LB; Beeuwkes R; Shier D; Greeley HP; Valtin H
    Adv Prostaglandin Thromboxane Res; 1980; 7():1009-13. PubMed ID: 7369014
    [No Abstract]   [Full Text] [Related]  

  • 8. Contribution of urine volume to the elevated urinary prostaglandin E in Bartter's syndrome and central and nephrogenic diabetes insipidus.
    Fichman M; Zia P; Zipser R
    Adv Prostaglandin Thromboxane Res; 1980; 7():1193-7. PubMed ID: 7369030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal excretion of prostaglandins E2 and F2alpha in diabetes insipidus rats.
    Dunn MJ; Greely HP; Valtin H; Kintner LB; Beeuwkes R
    Am J Physiol; 1978 Dec; 235(6):E624-7. PubMed ID: 736121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary adenosine 3',5'-monophosphate (cAMP) response to antidiuretic hormone in diabetes insipidus (DI): comparison between congenital nephrogenic DI type 1 and 2, and vasopressin sensitive DI.
    Ohzeki T
    Acta Endocrinol (Copenh); 1985 Apr; 108(4):485-90. PubMed ID: 2986401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-dependent stimulation of renal prostaglandin synthesis by deamino-8-D-arginine vasopressin in rats with hereditary diabetes insipidus.
    Walker LA; Frölich JC
    J Pharmacol Exp Ther; 1981 Apr; 217(1):87-91. PubMed ID: 7205662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hydrochlorothiazide and indomethacin treatment on renal function in nephrogenic diabetes insipidus.
    Jakobsson B; Berg U
    Acta Paediatr; 1994 May; 83(5):522-5. PubMed ID: 8086732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action of indomethacin in tubular defects.
    Usberti M; Pecoraro C; Federico S; Cianciaruso B; Guida B; Romano A; Grumetto L; Carbonaro L
    Pediatrics; 1985 Mar; 75(3):501-7. PubMed ID: 3856211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial cases of congenital nephrogenic diabetes insipidus type II: Remarkable increment of urinary adenosine 3',5'-monophosphate in response to antidiuretic hormone.
    Ohzeki T; Igarashi T; Okamoto A
    J Pediatr; 1984 Apr; 104(4):593-5. PubMed ID: 6323666
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of prostaglandins in the regulation of renal water excretion.
    Kramer HJ; Glänzer K; Düsing R
    Kidney Int; 1981 Jun; 19(6):851-9. PubMed ID: 7021956
    [No Abstract]   [Full Text] [Related]  

  • 16. Nephrogenic diabetes insipidus responsive to indomethacin plus dDAVP.
    Stasior DS; Kikeri D; Duel B; Seifter JL
    N Engl J Med; 1991 Mar; 324(12):850-1. PubMed ID: 1997862
    [No Abstract]   [Full Text] [Related]  

  • 17. Antidiuretic and PGE2 responses to AVP and dDAVP in subjects with central and nephrogenic diabetes insipidus.
    Moses AM; Scheinman SJ; Schroeder ET
    Am J Physiol; 1985 Mar; 248(3 Pt 2):F354-9. PubMed ID: 3856399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the Brattleboro rat in studies of the mechanism by which chlorpropamide enhances the action of vasopressin.
    Moses AM; Fenner R; Schroeder ET; Coulson R
    Ann N Y Acad Sci; 1982; 394():513-7. PubMed ID: 6295230
    [No Abstract]   [Full Text] [Related]  

  • 19. Indomethacin impairs water diuresis in the DI rat: role of prostaglandins independent of ADH.
    Stoff JS; Rosa RM; Silva P; Epstein FH
    Am J Physiol; 1981 Sep; 241(3):F231-7. PubMed ID: 6945054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital nephrogenic diabetes insipidus-vasopressin and prostaglandins in response to treatment with hydrochlorothiazide and indomethacin.
    Rascher W; Rosendahl W; Henrichs IA; Maier R; Seyberth HW
    Pediatr Nephrol; 1987 Jul; 1(3):485-90. PubMed ID: 3153321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.